Expression profiling and mutational analysis identifies a new subgroup of normal karyotype AML.

被引:0
|
作者
Debernardi, S [1 ]
Smith, M [1 ]
Lillington, DM [1 ]
Chaplin, T [1 ]
Rohatiner, A [1 ]
Lister, A [1 ]
Young, BD [1 ]
机构
[1] St Bartholomews Hosp, Canc Res UK, Dept Med Oncol, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1322
引用
收藏
页码:364A / 364A
页数:1
相关论文
共 50 条
  • [21] Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling
    Norbert Vey
    Marie-Joëlle Mozziconacci
    Agnès Groulet-Martinec
    Stéphane Debono
    Pascal Finetti
    Nadine Carbuccia
    Emmanuel Beillard
    Elizabeth Devilard
    Christine Arnoulet
    Diane Coso
    Danielle Sainty
    Luc Xerri
    Anne-Marie Stoppa
    Marina Lafage-Pochitaloff
    Catherine Nguyen
    Rémi Houlgatte
    Didier Blaise
    Dominique Maraninchi
    Françoise Birg
    Daniel Birnbaum
    François Bertucci
    Oncogene, 2004, 23 : 9381 - 9391
  • [22] Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways
    A Kohlmann
    L Bullinger
    C Thiede
    M Schaich
    S Schnittger
    K Döhner
    M Dugas
    H-U Klein
    H Döhner
    G Ehninger
    T Haferlach
    Leukemia, 2010, 24 : 1216 - 1220
  • [23] Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways
    Kohlmann, A.
    Bullinger, L.
    Thiede, C.
    Schaich, M.
    Schnittger, S.
    Doehner, K.
    Dugas, M.
    Klein, H-U
    Doehner, H.
    Ehninger, G.
    Haferlach, T.
    LEUKEMIA, 2010, 24 (06) : 1216 - 1220
  • [24] High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial
    Patel, Jay P.
    Abdel-Wahab, Omar
    Gonen, Mithat
    Figueroa, Maria E.
    Fernandez, Hugo F.
    Sun, Zhuoxin
    Racevskis, Janis
    van Vlierberghe, Pieter
    Dolgalev, Igor
    Cheng, Janice
    Viale, Agnes
    Socci, Nicholas
    Heguy, Adriana
    Ketterling, Rhett
    Gallagher, Robert E.
    Litzow, Mark R.
    Rowe, Jacob M.
    Ferrando, Adolfo
    Paietta, Elisabeth
    Tallman, Martin S.
    Melnick, Ari M.
    Levine, Ross
    BLOOD, 2010, 116 (21) : 370 - 371
  • [25] The hedgehog signalling pathway represents a new target in AML patients with normal karyotype
    Landwerlin, K.
    Hartmann, D.
    Herchenbach, D.
    Schmitt-Graeff, A.
    Veelken, H.
    Dierks, C.
    ONKOLOGIE, 2010, 33 : 105 - 106
  • [26] Predicting survival in AML with a normal karyotype: Old and new molecular risk factors
    Metzeler, K. H.
    Hiddemann, W.
    Spiekermann, K.
    Braess, J.
    Buske, C.
    Bohlander, S. K.
    ANNALS OF HEMATOLOGY, 2008, 87 : S70 - S73
  • [27] Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse
    Wang, Eunice S.
    Sait, Sheila N. J.
    Gold, David
    Mashtare, Terry
    Starostik, Petr
    Ford, Laurie Ann
    Wetzler, Meir
    Nowak, Norma J.
    Deeb, George
    CANCER GENETICS AND CYTOGENETICS, 2010, 202 (02) : 101 - 107
  • [28] Gene expression profiling in AML and MDS identifies genes located on 5q which are consistently lower expressed in cases with 5q deletion as compared to cases with normal karyotype.
    Schoch, C
    Kohlmann, A
    Kern, W
    Merk, S
    Hiddemann, W
    Dugas, M
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (11) : 159A - 159A
  • [29] Retrospective analysis of post-remission modalities in AML patients with normal karyotype
    Chae, Yee Soo
    Sohn, Sang Kyun
    Kim, Jong Gwang
    Cho, Yoon Young
    Moon, Joon Ho
    Ahn, Byung Min
    Kim, Shi Nae
    BLOOD, 2007, 110 (11) : 132B - 132B
  • [30] Whole genome and transcriptome analysis of a novel AML cell line with a normal karyotype
    Gosse, Geraldine
    Celton, Magalie
    Lamontagne, Vikie
    Forest, Audrey
    Wilhelm, Brian T.
    LEUKEMIA RESEARCH, 2015, 39 (07) : 709 - 718